Norovirus GI.4/GII.4 Bivalent VLP Vaccine (Icon Genetics GmbH)

N/A

Report date: 2024/04/03 14:19:32

Base Information

Drug NameNorovirus GI.4/GII.4 Bivalent VLP Vaccine (Icon Genetics GmbH)

Drug Alias NamerNV-2v

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Viral vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsNorovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesIcon Genetics Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesIcon Genetics Gmbh

Inactive CompaniesN/A

Active IndicationsNorovirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A